Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Falcoff

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Cancer|April 15, 1986
Interferon alpha in the treatment of hairy cell leukemiaS Castaigne, F Sigaux, K Cantell, et al.
Leukemia Research|January 1, 1988
Action of interferon-alpha on hairy cell leukemia: expression of specific receptors and (2'-5')oligo (A) synthetase in tumor cells from sensitive and resistant patientsC Billard, D Ferbus, F Sigaux, et al.
Infection and Immunity|February 1, 1978
Induction of interferon synthesis in mice by fractions from NocardiaR Barot-Ciorbaru, J Wietzerbin, J F Petit, et al.
Antiviral Research|September 1, 1982
Synergistic activities of type I (alpha, beta) and type II (gamma) murine interferonsA Zerial, A G Hovanessian, S Stefanos, et al.
International Journal of Dermatology|November 1, 1992
Lepromatous leprosy treated with recombinant interferon gamma: cutaneous histologic changesO Bottasso, S Besuschio, V Merlin, et al.
Leukemia|August 1, 1987
Proliferative response of hairy cells to B cell growth factor (BCGF): in vivo inhibition by interferon-alpha and in vitro effects of interferon-alpha, -beta, and -gammaE Genot, C Billard, F Sigaux, et al.
Blood|March 1, 1986
Treatment of hairy cell leukemia with recombinant alpha interferon: II. In vivo down-regulation of alpha interferon receptors on tumor cellsC Billard, F Sigaux, S Castaigne, et al.
Blood|March 1, 1986
Treatment of hairy cell leukemia with recombinant alpha interferon: I. Quantitative study of bone marrow changes during the first months of treatmentG Flandrin, F Sigaux, S Castaigne, et al.
Bulletin Du Cancer|January 1, 1984
The value of a radioimmunological monitoring in cancer patients treated with interferon alphaJ Bernier, A Reuter, Y Vrindts-Gevaert, et al.
Cancer|July 15, 1986
Clinical phase II trial of recombinant DNA interferon (interferon alpha 2b) in patients with metastatic malignant melanomaT Dorval, T Palangie, M Jouve, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Cancer|April 15, 1986
Interferon alpha in the treatment of hairy cell leukemiaS Castaigne, F Sigaux, K Cantell, et al.
Leukemia Research|January 1, 1988
Action of interferon-alpha on hairy cell leukemia: expression of specific receptors and (2'-5')oligo (A) synthetase in tumor cells from sensitive and resistant patientsC Billard, D Ferbus, F Sigaux, et al.
Infection and Immunity|February 1, 1978
Induction of interferon synthesis in mice by fractions from NocardiaR Barot-Ciorbaru, J Wietzerbin, J F Petit, et al.
Antiviral Research|September 1, 1982
Synergistic activities of type I (alpha, beta) and type II (gamma) murine interferonsA Zerial, A G Hovanessian, S Stefanos, et al.
International Journal of Dermatology|November 1, 1992
Lepromatous leprosy treated with recombinant interferon gamma: cutaneous histologic changesO Bottasso, S Besuschio, V Merlin, et al.
Leukemia|August 1, 1987
Proliferative response of hairy cells to B cell growth factor (BCGF): in vivo inhibition by interferon-alpha and in vitro effects of interferon-alpha, -beta, and -gammaE Genot, C Billard, F Sigaux, et al.
Blood|March 1, 1986
Treatment of hairy cell leukemia with recombinant alpha interferon: II. In vivo down-regulation of alpha interferon receptors on tumor cellsC Billard, F Sigaux, S Castaigne, et al.
Blood|March 1, 1986
Treatment of hairy cell leukemia with recombinant alpha interferon: I. Quantitative study of bone marrow changes during the first months of treatmentG Flandrin, F Sigaux, S Castaigne, et al.
Bulletin Du Cancer|January 1, 1984
The value of a radioimmunological monitoring in cancer patients treated with interferon alphaJ Bernier, A Reuter, Y Vrindts-Gevaert, et al.
Cancer|July 15, 1986
Clinical phase II trial of recombinant DNA interferon (interferon alpha 2b) in patients with metastatic malignant melanomaT Dorval, T Palangie, M Jouve, et al.
Pageof 6